


NeuroRevolution Revenue
Pharmaceutical Manufacturing • Houston, Texas, United States • 1-10 Employees
NeuroRevolution revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at NeuroRevolution
Phillip Reynolds
Owner
Company overview
| Headquarters | Houston, Texas, United States |
| NAICS | 3254 |
| Keywords | Pharmaceuticals, Sleep, Pain, EEG, Disease Models, Pharmacology, Drug Screening, Conract Research, Neuro |
| Founded | 2009 |
| Employees | 1-10 |
About NeuroRevolution
NeuroRevolution, Inc. is a preclinical contract research organization (CRO) dedicated to the evaluation of new drug candidates and targets for neuropsychiatric disorders and related research programs. We are experienced and set up for extremely high-capacity testing. Our rapid turn around of data and results will provide your organization with a strategic advantage. We have drug validated behavioral assays in the following areas: We are skilled in various types of dosing, including: * Anxiety * Depression * Psychosis * Pain * Sleep (EEG-telemetry) * Learning and Memory * General phenotypic assessment/ Behavioral toxicology * IP * PO * SC * ICV * minipump
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
NeuroRevolution has never raised funding before.
Frequently asked questions
4.8
40,000 users



